Term
|
Definition
| host defenses that afford protection against any kind of pathogen |
|
|
Term
|
Definition
| the ability, obtained during the life of the individual, to produce specific antibodies and T cells |
|
|
Term
|
Definition
| immunity brought about by antibodies |
|
|
Term
|
Definition
| a structure resembling a lymph node, exists in birds, has no known function |
|
|
Term
|
Definition
| lymphoid organ found in the upper chest, plays a role in immunity |
|
|
Term
|
Definition
| recognize antigens and make specific antibodies against them |
|
|
Term
|
Definition
| mature of the influence of the thymus (basis of cellular immunity) |
|
|
Term
|
Definition
| an immune response that involves T cells binding to an antigen presented on antigen-presenting cells; T cells then differentiate into several types of effector T cells |
|
|
Term
|
Definition
| molecules on T cells that recognize antigens |
|
|
Term
|
Definition
| any substance that causes antibody formation |
|
|
Term
| epitopes or antigenic determinants |
|
Definition
| a specific region on the surface of an antigen against which antibodies are formed |
|
|
Term
|
Definition
| a substance of low molecular weight that does not cause the formation of antibodies by itself but does so when combined with a carrier molecule |
|
|
Term
|
Definition
| globulin proteins (immunoglobulins); made in response to an antigen and can recognize and bind to an anitgen |
|
|
Term
|
Definition
|
|
Term
|
Definition
| each antibody has at lease two identical binding sites |
|
|
Term
|
Definition
| number of antigen-binding sites on an antibody; (two binding sides = bivalent) |
|
|
Term
|
Definition
| bivalent monomer has the simplest molecular structure |
|
|
Term
|
Definition
| an antigen that requires a T(subH)cell for antibody production; an antigen that will stimulate the formation of antibodies only with the assistance of T helper cells |
|
|
Term
| major histocompatibility complex (MHC) |
|
Definition
| a collection of genes that encode molecules of genetically diverse glycoproteins that are found on the plasma membranes of mammalian nucleated cells |
|
|
Term
|
Definition
| a cell that is an activated B cell differentiates into; plasma cells manufacture antibodies |
|
|
Term
|
Definition
| responsible for the enhanced secondary phase to an antigen |
|
|
Term
|
Definition
| the development of clones of B and T cells against a specific antigen |
|
|
Term
|
Definition
| the elimination of B and T cells that react with self |
|
|
Term
|
Definition
| antigens that stimulate B cells directly without the help of T cells |
|
|
Term
|
Definition
| when an antibody encounters an antigen for which it is specific; rapidly forms |
|
|
Term
|
Definition
| the strength of the bond between an antigen and an antibody |
|
|
Term
|
Definition
| percentage of false positive results given by a diagnostic test |
|
|
Term
|
Definition
| antibodies cause antigens to clump together |
|
|
Term
|
Definition
| the enhancement of phagocytosis by coating microorganisms with certain serum proteins (opsonins); also called immune adherence |
|
|
Term
| antibody-dependent cell-mediated cytotoxicity (ADCC) |
|
Definition
| the killing of antibody-coated cells by natural killer cells and leukocytes |
|
|
Term
|
Definition
| IgG antibodies inactivate microbes by blocking their attachment to host cells and they neutralize toxins in a similar manner |
|
|
Term
| activation of the complement system |
|
Definition
| either IgG or IgM antibodies may trigger |
|
|
Term
|
Definition
| reflects a weeding-out process; T cells that will not specifically recognize self-molecules of MHC |
|
|
Term
| microfold cells (M cells) |
|
Definition
| intestinal cells that take up and transfer antigens to lymphocytes |
|
|
Term
|
Definition
| M cells located over; secondary lymphoid organs located on the intestinal wall |
|
|
Term
| antigen-presenting cells (APCs) |
|
Definition
| recognition of antigens by a T cell requires that they be first processed by specialized APCs |
|
|
Term
| T helper cells (T [subH]) |
|
Definition
| a specialized T cell that often interacts with an antigen before B cells interact with the antigen |
|
|
Term
| T cytotoxic cells (T [subC]) |
|
Definition
| a specialized T cell that destroys infected cells presenting antigens |
|
|
Term
| cytotoxic T lymphocyte (CTL) |
|
Definition
| an activated T(subC) cell; kills cells presenting endogenous antigens |
|
|
Term
|
Definition
|
|
Term
| clusters of differentiation (CD) |
|
Definition
| T cells are also classified by certain glycoproteins on their surface |
|
|
Term
|
Definition
| cytokines produced by mostly activate those cells related to important elements of cellular immunity, such as delayed hypersensitivity and are also responsible for activation of macrophages |
|
|
Term
|
Definition
| produce cytokines that are associated primarily with the production of antibodies, especially IgE, that are important in allergic reactions |
|
|
Term
|
Definition
| generally synthesized within the cell and are mostly of viral or parasitic origin |
|
|
Term
|
Definition
| a CTL attaches to the target cell and releases pore-forming protein |
|
|
Term
|
Definition
| proteases that induce apoptosis, are then able to enter through the pore |
|
|
Term
|
Definition
|
|
Term
| T regulatory cells (T reg) |
|
Definition
| subset of CD4+ helper cells and are distinguished by carrying an additional CD25 molecule; primary function is to combat autoimmunity by suppressing T cells that escape deletion in the thymus without the necessary "education" to avoid reacting against the body's self |
|
|
Term
|
Definition
| characterized by long extensions called dendrites because they resemble the dendrites of nerve cells |
|
|
Term
|
Definition
| are cells usually found in a resting state |
|
|
Term
|
Definition
| a macrophage that has increased phagocytic ability and other functions after exposure to mediators released by T cells after stimulation by antigens |
|
|
Term
| natural killer (NK) cells |
|
Definition
| a lymphoid cell that destroys tumor cells and virus-infected cells |
|
|
Term
| antibody-dependent cell-mediated cytotoxicity (ADCC) |
|
Definition
| the killing of antibody-coated cells by natural killer cells and leukocytes |
|
|
Term
|
Definition
| communication required is mediated by chemical messengers called: |
|
|
Term
|
Definition
| cytokines that serve as communicators between leukocytes are known as: |
|
|
Term
|
Definition
| a family of small cytokines that induces migration of leukocytes into areas of infection or tissue damage |
|
|
Term
|
Definition
| a specific group of cytokines; alpha- and beta-IFNs are antiviral proteins produced by certain animal cells in response to a viral infection; gamma-IFN stimulates macrophage activity |
|
|
Term
| tumor necrosis factor (TNF) |
|
Definition
| cytokines are a strong factor in inflammatory reactions of autoimmune diseases such as rheumatoid arthritis |
|
|
Term
|
Definition
| family of cytokines; function in controlling the pathways by which stem cells develop into different red or white blood cells |
|
|
Term
|
Definition
| feedback loop occasionally gets out of control, resulting in a harmful overproduction of cytokines |
|
|
Term
|
Definition
| antibody production in resonse to the first contact with an antigen |
|
|
Term
|
Definition
| (or memory response or amnestic response) a rapid rise in antibody titer following exposure to an antigen after the primary response to that antigen |
|
|
Term
| naturally acquired active immunity |
|
Definition
| develops when a person is exposed to antigens, becomes ill, and then recovers |
|
|
Term
| naturally acquired passive immunity |
|
Definition
| involves the natural transfer of antibodies from a mother to her infant |
|
|
Term
| artificially acquired active immunity |
|
Definition
|
|
Term
| vaccination (also called immunization) |
|
Definition
| process of conferring immunity by administering a vaccine |
|
|
Term
|
Definition
| a preparation of killed, inactivated, or attenuated microorganisms or toxoids to induce artificially acquired active immunity |
|
|
Term
| artificially acquired passive immunity |
|
Definition
| involves the injection of antibodies (rather than antigens) into the body |
|
|
Term
|
Definition
| a blood-derived fluid containing antibodies |
|
|
Term
|
Definition
| the branch of immunology that studies blood serum and antigen-antibody reactions in vitro |
|
|
Term
|
Definition
| the serum fraction containing immunoglobulins (antibodies); also called immune serum globulin |
|
|
